SANTANDREA, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 1.616
NA - Nord America 1.388
EU - Europa 779
SA - Sud America 224
AF - Africa 83
OC - Oceania 11
Totale 4.101
Nazione #
US - Stati Uniti d'America 1.327
CN - Cina 497
SG - Singapore 419
IT - Italia 278
HK - Hong Kong 185
BR - Brasile 171
VN - Vietnam 169
GB - Regno Unito 108
KR - Corea 82
DE - Germania 75
RU - Federazione Russa 63
SE - Svezia 56
IN - India 49
FR - Francia 40
ID - Indonesia 38
EG - Egitto 34
FI - Finlandia 32
CA - Canada 27
MX - Messico 27
NL - Olanda 26
AR - Argentina 25
PK - Pakistan 25
IQ - Iraq 24
IR - Iran 23
ZA - Sudafrica 19
BD - Bangladesh 18
PL - Polonia 17
TR - Turchia 14
LT - Lituania 13
UA - Ucraina 12
AU - Australia 11
JP - Giappone 11
PH - Filippine 11
CO - Colombia 10
EC - Ecuador 9
ES - Italia 9
IL - Israele 9
AT - Austria 7
CH - Svizzera 7
NG - Nigeria 7
SA - Arabia Saudita 7
IE - Irlanda 6
MA - Marocco 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
PT - Portogallo 5
BG - Bulgaria 4
DZ - Algeria 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
AM - Armenia 3
ET - Etiopia 3
PA - Panama 3
SN - Senegal 3
BF - Burkina Faso 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.101
Città #
Santa Clara 280
Singapore 262
Ashburn 243
Hefei 227
Hong Kong 173
San Jose 116
Seoul 69
Ho Chi Minh City 59
Beijing 58
London 56
New York 45
Los Angeles 44
Council Bluffs 43
Milan 36
Chandler 35
Hanoi 29
Chicago 26
The Dalles 26
Helsinki 25
Cairo 23
Jakarta 23
São Paulo 23
Fairfield 21
Shanghai 21
Buffalo 20
Lauterbourg 20
Nyköping 20
Kent 16
Munich 16
Schiffdorf 16
Bologna 15
Moscow 15
Orem 15
Rome 15
Warsaw 15
Johannesburg 14
Salt Lake City 11
Amsterdam 10
Da Nang 10
Dallas 10
Mexico City 10
Naples 10
Florence 9
Islamabad 9
Nuremberg 9
Tokyo 9
Brembate di Sopra 8
Denver 8
Rio de Janeiro 8
Wuhan 8
Atlanta 7
Baghdad 7
Cambridge 7
Guayaquil 7
Haiphong 7
Houston 7
Istanbul 7
Montreal 7
Bari 6
Catania 6
Dhaka 6
Dublin 6
Giza 6
Portsmouth 6
Redondo Beach 6
Toronto 6
Turin 6
Amman 5
Ann Arbor 5
Bagno a Ripoli 5
Belo Horizonte 5
Bengaluru 5
Boston 5
Brooklyn 5
Campi Bisenzio 5
Charlotte 5
Kunming 5
Lagos 5
Lahore 5
Manchester 5
Migliarino 5
Parma 5
Poplar 5
San Diego 5
Seattle 5
Turku 5
Austin 4
Belgrade 4
Bremen 4
Chennai 4
Düsseldorf 4
Erbil 4
Geneva 4
Genoa 4
Huế 4
Jeddah 4
Karachi 4
Miami 4
Modena 4
Mumbai 4
Totale 2.550
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 540
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 224
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 208
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 190
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 189
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 187
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 176
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 168
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 161
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 159
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 159
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 154
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 151
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 143
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 138
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 137
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 134
PRAME expression in cellular neurothekeoma: A study of 11 cases 134
Digital spatial profiling for pathologists 126
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 125
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 120
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 95
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 93
null 83
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 82
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 59
Totale 4.135
Categoria #
all - tutte 15.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202267 11 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20262.254 221 157 221 295 332 94 291 113 271 215 44 0
Totale 4.135